The Trump administration is expected to announce tariffs on pharmaceuticals "in the next month or two," an official said. | ...

As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...

On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companie | ...

Employees of companies regulated by the FDA—such as pharmas or biotechs—are no longer allowed to serve as members of FDA ...